AKLIEF

This brand name is authorized in Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Malta, Netherlands, Poland, Romania, United States

Active ingredients

The drug AKLIEF contains one active pharmaceutical ingredient (API):

1 Trifarotene UNII 0J8RN2W0HK - TRIFAROTENE

Trifarotene is an agonist of retinoic acid receptors (RAR), with particular activity at the gamma subtype of RAR. Stimulation of RAR results in modulation of target genes which are associated with various processes, including cell differentiation and mediation of inflammation. Trifarotene cream is used for the topical treatment of acne vulgaris. Read about Trifarotene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AKLIEF Cream	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D10AD06		D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AD Retinoids for topical use in acne
Discover more medicines within D10AD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02494175
Country: EE	Ravimiamet	Identifier(s): 1848843, 1848865, 1848876, 1848887
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 85017
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 515832
Country: FR	Base de données publique des médicaments	Identifier(s): 63631908
Country: HK	Department of Health Drug Office	Identifier(s): 67256
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-888420870
Country: MT	Medicines Authority	Identifier(s): MA117/01501
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 203785
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100412716
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68352001, W68352002, W68352003, W68352004
Country: US	FDA, National Drug Code	Identifier(s): 0299-5935